Nargess Arandi

About Nargess Arandi

Nargess Arandi, With an exceptional h-index of 13 and a recent h-index of 11 (since 2020), a distinguished researcher at Shiraz University of Medical Sciences, specializes in the field of Immunology of Hematologic Malignancies.

His recent articles reflect a diverse array of research interests and contributions to the field:

Higher peripheral blood IFN-γ-/IL-4+ Th2 lymphocytes are associated with lower rate of relapse in patients with lymphoma

The impact of selenium on regulatory T cell frequency and immune checkpoint receptor expression in patients with diffuse large B cell lymphoma (DLBCL)

Aberrant peripheral blood CD4+ CD25+ FOXP3+ regulatory T cells/T helper-17 number is associated with the outcome of patients with lymphoma

Nargess Arandi Information

University

Position

Hematology Research Center

Citations(all)

553

Citations(since 2020)

316

Cited By

371

hIndex(all)

13

hIndex(since 2020)

11

i10Index(all)

16

i10Index(since 2020)

13

Email

University Profile Page

Google Scholar

Nargess Arandi Skills & Research Interests

Immunology of Hematologic Malignancies

Top articles of Nargess Arandi

Higher peripheral blood IFN-γ-/IL-4+ Th2 lymphocytes are associated with lower rate of relapse in patients with lymphoma

Immunological Investigations

2022/2/17

The impact of selenium on regulatory T cell frequency and immune checkpoint receptor expression in patients with diffuse large B cell lymphoma (DLBCL)

Cancer Immunology, Immunotherapy

2021/10

Aberrant peripheral blood CD4+ CD25+ FOXP3+ regulatory T cells/T helper-17 number is associated with the outcome of patients with lymphoma

Cancer Immunology, Immunotherapy

2020/9

See List of Professors in Nargess Arandi University(Shiraz University of Medical Sciences)